Advertisement
Research Article| Volume 20, ISSUE 2, P235-255, June 2000

Human Papillomavirus: Epidemiology, Transmission, and Pathogenesis

  • Jeanne Carr
    Correspondence
    Address reprint requests to: Jeanne Carr, PhD, Clinical Pathology Department, William Beaumont Hospital, 3601 West Thirteen Mile Road, Royal Oak, MI 48073
    Affiliations
    From the Molecular Probe and BSL-3 Laboratories, William Beaumont Hospital, Royal Oak, Michigan

    Clinical Pathology Department, William Beaumont Hospital, Royal Oak, Michigan
    Search for articles by this author
  • Tibor Gyorfi
    Affiliations
    Clinical Pathology Department, William Beaumont Hospital, Royal Oak, Michigan
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30060-X
Human Papillomavirus: Epidemiology, Transmission, and Pathogenesis
Previous ArticlePreface
Next ArticleHuman Papillomavirus in Cervical Neoplasia: Role, Risk Factors, and Implications
      This paper is only available as a PDF. To read, Please Download here.
      Papillomaviruses are double-stranded DNA viruses that are species-specific. Currently, more than 200 types of human papillomavirus (HPV) have been identified as infecting humans. HPV is very site-specific and infects the squamous epithelium. Clinical manifestations range from warts to invasive cancer.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Alloub M.I.
        • Barr B.B.B.
        • Me Laren K.M.
        • et al.
        Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts.
        BMJ. 1989; 298: 153
        • Arany I.
        • Tyring S.K.
        Status of local cellular immunity in interferon-responsive and - nonresponsive human papillomavirus-associated lesions.
        Sex Transm Dis. 1996; 23: 475
        • Atula S.
        • Auvinen E.
        • Grenman R.
        • et al.
        Human papillomavirus and Epstein-Barr virus in epithelial carcinomas of the head and neck region.
        Anticancer Res. 1997; 17: 4427
        • Azocar J.
        • Abad S.M.
        • Acosta H.
        • et al.
        Prevalence of cervical dysplasia and HPV infection according to sexual behavior.
        Int J Cancer. 1990; 45: 622
        • Barrett T.J.
        • Silbar J.D.
        • McGinley J.P.
        Genital warts—a venereal disease.
        JAMA. 1954; 154: 333
        • Bauer H.M.
        • Ting Y.
        • Greer C.E.
        • et al.
        Genital human papillomavirus infection in female university students as determined by a PCR-based method.
        JAMA. 1991; 265: 472
        • Becker T.M.
        Genital human papillomavirus infection: An epidemiological perspective.
        in: Norrby S.R. New Antiviral Strategies. Churchill Livingstone, Edinburg1988: 44
        • Becker T.M.
        • Blount J.F.
        • Guinan M.E.
        Trends in genital herpes infections among private practitioners in the United States, 1996-1981.
        JAMA. 1985; 253: 1601
        • Bedell M.A.
        • Jones K.H.
        • Laimins L.A.
        The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 343 and rat-1 cells.
        J Virol. 1987; 61: 3635
        • Bender M.
        Concepts of wart regression.
        Arch Dermatol. 1986; 122: 644
        • Berman A.
        • Winkleman R.K.
        Involuting common warts: Clinical and histopathologic findings.
        J Am Acad Dermatol. 1980; 3: 356
        • Beutner K.R.
        Human papillomavirus and human disease.
        Am J Med. 1997; 102: 9
        • Bishop P.E.
        • Me Millan A.
        • Fletcher S.
        An immunohistological study of spontaneous regression of condylomata acuminata.
        Genitourin Med. 1990; 66: 79
        • Bosch F.X.
        • Castellsague X.
        • Munoz N.
        • et al.
        Male sexual behavior and human papillomavirus DNA: Key risk factors for cervical cancer in Spain.
        J Natl Cancer Inst. 1996; 88: 1060
        • Bosch F.X.
        • Manos M.M.
        • Munoz N.
        • et al.
        Prevalence of human papillomavirus in cervical cancer: A worldwide perspective.
        J Natl Cancer Inst. 1995; 87: 796
        • Bosch F.X.
        • Munoz N.
        • de Sanjose S.
        Human papillomavirus and other risk factors for cervical cancer.
        Biomed Pharmacother. 1997; 51: 268
        • Brinton L.A.
        • Reeves W.C.
        • Brenes M.M.
        • et al.
        Oral contraceptive use and risk of invasive cervical cancer.
        Int J Epidemiol. 1990; 19: 4
        • Brown D.R.
        • Chin M.T.
        • Strike D.G.
        Identification of human papillomavirus type 11E4 gene products in human tissue implants from nude mice.
        Virology. 1988; 165: 262
        • Cason J.
        • Kaye J.N.
        • Best J.M.
        Non-sexual acquisition of human genital papillomavirus.
        Papillomavirus Rep. 1995; 6: 1
        • Chee Y.H.
        • Namkoong S.E.
        • Kim D.H.
        • et al.
        Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins.
        Gynecol Oncol. 1995; 57: 226
        • Ciuffo G.
        Innesto positivo con filtrato di verruca volgare.
        Giorn Ital Mai Venereol. 1907; 48: 12
        • Clavel C.E.
        • Huu V.P.
        • Durlach A.P.
        • et al.
        Mucosal oncogenic human papillomaviruses and extragenital Bowen disease.
        Cancer. 1999; 86: 282
        • Coleman N.
        • Birley H.D.
        • Renton A.M.
        • et al.
        Immunological events in regressing genital warts.
        Am J Clin Pathol. 1994; 102: 768
        • de Villiers E-M
        Heterogeneity of the human papillomavirus group.
        J Virol. 1989; 63: 4898
        • de Villiers E-M
        Papillomavirus and HPV typing.
        Clin Dermatol. 1997; 15: 199
        • de Villiers E.M.
        • Weidauer H.
        • Otto H.
        • et al.
        Papillomavirus DNA in human tongue carcinomas.
        Int J Cancer. 1985; 36: 575
        • Dianzani C.
        • Calvieri S.
        • Pierangeli A.
        • et al.
        The detection of human papillomavirus in skin tags.
        Br J Dermatol. 1998; 138: 649

      28. Diepgen TL, Simon M, Eysenbach G et al: Dermatology Internet Service: http://www.dermis.net

        • Doorbar J.
        • Ely S.
        • Sterling J.
        • et al.
        Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network.
        Nature. 1991; 352: 824
        • Dürst M.
        • Glitz D.
        • Schneider A.
        • et al.
        Human papillomavirus 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization.
        Virology. 1992; 189: 132
        • Dürst M.
        • Schwarz E.
        • Gissmann L.
        Integration and persistence of human papillomavirus DNA in genital tumors.
        Banbury Reports. 1986; 21: 273
        • Dyson N.
        • Howley P.M.
        • Munger K.
        • et al.
        The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
        Science. 1989; 243: 934
        • Ferenczy A.
        Epidemiology and clinical pathophysiology of condyloma acuminata.
        Am J Obstet Gynecol. 1995; 131: 912
        • Ferenczy A.
        • Bergeron C.
        • Richart R.M.
        Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections.
        Obstet Gynecol. 1989; 74: 950
        • Franco E.L.
        • Villa L.L.
        • Ruiz A.
        • et al.
        Transmission of cervical papillomavirus infection by sexual activity: Differences between high and low oncogenic types.
        J Infect Dis. 1995; 172: 756
        • Galloway D.A.
        • Jenison S.A.
        Characterization of the humoral immune response to genital papillomaviruses.
        Mol Biol Med. 1990; 7: 59
        • Goihman-Yahr M.
        • Gernandex J.
        • Boatswain A.
        • et al.
        Unilateral dinitrochlorobenzene immunopathy of recalcitrant warts.
        Lancet. 1978; 1: 447
        • Goldschmidt H.
        • Klingman A.M.
        Experimental inoculation of humans with ectodermo-tropic viruses.
        J Invest Dermatol. 1958; 31: 175
        • Gradilone A.
        • Vercillo R.
        • Napoliatno M.
        • et al.
        Prevalence of human papillomavirus, cytomegalovirus, and Epstein-Barr virus in the cervix of healthy women.
        J Med Virol. 1996; 50: 1
        • Greenspan D.
        • de Villiers E.M.
        • Greenspan J.S.
        • et al.
        Unusual HPV types in oral warts in association with HIV infection.
        J Oral Pathol. 1988; 17: 482
        • Guo W.
        • Kanf M.K.
        • Kim H.J.
        • et al.
        Immortalization of human keratinocytes is associated with elevation of telomerase activity and shortening of telomere length.
        Oncol Rep. 1998; 5: 799
        • Gutman L.T.
        • Herman-Giddens M.E.
        • Phelps W.C.
        Transmission of human genital papillomavirus disease: Comparison of data from adults and children.
        Pediatrics. 1993; 91: 31
        • Hildesheim A.
        • Schiffman M.H.
        • Gravitt P.E.
        • et al.
        Persistence of type-specific human papillomavirus infection among cytologically normal women.
        J Infect Dis. 1994; 169: 235
        • Hines J.F.
        • Jenson A.B.
        Human papillomaviruses.
        in: Connor D.H. Chandler F.W. Mantz H.J. Pathology of Infectious Diseases, vol 1. Appleton & Lange, Stamford, CT1997: 199
        • Hippeläinen M.
        • Syrjänen S.
        • Hippeläinen M.
        • et al.
        Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: A study on Finnish conscripts.
        Sex Transm Dis. 1993; 20: 321
        • Howett M.K.
        • Kreider J.W.
        • Cockley K.D.
        Human xenografts. A model system for human papillomavirus infection.
        Intervirology. 1990; 31: 109
        • Jalal H.
        • Sanders C.M.
        • Prime S.S.
        • et al.
        Detection of human papillomavirus type 16 DNA in oral squames from normal young adults.
        J Oral Pathol Med. 1992; 21: 465
        • Jenson A.B.
        • Kurman R.J.
        • Lancaster W.D.
        Detection of papillomavirus common antigens in lesions of skin and mucosa.
        Clin Dermatol. 1985; 3: 56
        • Joklik W.K.
        • Willett M.P.
        • Amos D.B.
        • et al.
        Human papillomavirus.
        in: Joklik W.K. Willett M.P. Amos D.B. Zinsser Microbiology. ed 20. Appleton & Lange, Norwalk, CT1992: 975
        • Kataja V.
        • Syrjänen S.
        • Yliskoski M.
        • et al.
        Risk factors associated with cervical human papillomavirus infections: A case-control study.
        Am J Epidemiol. 1993; 138: 735
        • Kay S.
        • Frable W.J.
        • Hume D.M.
        Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation.
        Cancer. 1970; 26: 1048
        • Kenney J.W.
        Ethnic differences in risk factors associated with genital human papillomavirus infections.
        J Adv Nurs. 1996; 23: 1221
        • Kersemaekers A-MF
        • Kenter G.G.
        • Hermans J.
        • et al.
        Allelic loss and prognosis in carcinoma of the uterine cervix.
        Int J Cancer. 1998; 79: 411
        • Kirchner H.
        Immunobiology of human papillomavirus infection.
        Prog Med Virol. 1986; 33: 1
        • Kiviat N.B.
        • Koutsky L.A.
        • Critchlow M.S.
        Prevalence and cytologic manifestations of human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 35, 42, 44, 51 and 56 among 500 consecutive women.
        Int J Gynecol Pathol. 1992; 11: 197
        • Klingelhutz A.J.
        • Foster S.A.
        • McDougall J.K.
        Telomerase activation by the E6 gene product of human papillomavirus type 16.
        Nature. 1996; 380: 79
        • Kosary C.L.
        • Ries L.A.G.
        • Miller B.A.
        • et al.
        SEER Cancer Statistics Review, 1973–1992: Tables and Graphs. NIH Pub. No. 96-2789. National Cancer Institute, Bethesda, MD1995
        • Koutsky L.
        Epidemiology of genital human papillomavirus infection.
        Am J Med. 1997; 102: 3
        • Koutsky L.A.
        • Galloway D.A.
        • Holmes K.K.
        Epidemiology of genital human papillomavirus infection.
        Epidemiol Rev. 1988; 10: 122
        • Kreider J.W.
        • Patrick S.D.
        • Cladel N.M.
        • et al.
        Experimental infection with human papillomavirus type 1 of human hand and foot skin.
        Virology. 1990; 177: 415
        • Lambropoulos A.F.
        • Dimitrakopoulos J.
        • Frangoulides E.
        • et al.
        Incidence of human papillomavirus 6, 11, 16, 18 and 33 in normal oral mucosa of a Greek population.
        Eur J Oral Sei. 1997; 105: 294
        • Lenner P.
        • Dillner J.
        • Wiklund F.
        • et al.
        Serum antibody responses against human papillomavirus in relation to tumor characteristics, response to treatment, and survival in carcinoma of the uterine cervix.
        Cancer Immunol Immunother. 1995; 40: 201
        • Ley C.
        • Bauer H.M.
        • Reingold A.
        • et al.
        Determinants of genital human papillomavirus infection in young women.
        J Natl Cancer Inst. 1991; 83: 997
        • Lorincz A.T.
        • Reid R.
        • Jenson A.B.
        • et al.
        Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types.
        Obstet Gynecol. 1992; 79: 328
        • Maitland N.J.
        • Cox M.F.
        • Lynas C.
        • et al.
        Detection of human papillomavirus DNA in biopsies of human oral tissue.
        Br J Cancer. 1987; 56: 245
        • Massing A.M.
        • Epstein W.L.
        Natural history of warts.
        Arch Dermatol. 1963; 87: 74
        • Matis W.L.
        • Triana A.
        • Shapiro R.
        • et al.
        Dermatologic findings associated with human immunodeficiency virus infection.
        J Am Acad Dermatol. 1987; 17: 746
        • McDonnell P.J.
        • McDonnell J.M.
        • Kessis T.
        • et al.
        Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hybridization with radioactive probes.
        Hum Pathol. 1987; 18: 1115
        • Melton J.L.
        • Rasmussen J.E.
        Clinical manifestations of human papillomavirus infection in nongenital sites.
        Dermatol Clin. 1991; 9: 219
        • Meyers C.
        • Frattini M.G.
        • Hudson J.B.
        • et al.
        Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.
        Science. 1992; 257: 971
        • Mounts P.
        • Shah K.V.
        • Kashima H.
        Viral etiology of juvenile-and adult-onset squamous papilloma of the larynx.
        Proc Natl Acad Sei U S A. 1982; 79: 5425
        • Murray R.
        • Hobbs J.
        • Payne B.
        Possible clonal origin of common warts (verruca vulgaris).
        Nature. 1971; 232: 51
        • Naghashfar Z.
        • McDonnell P.J.
        • McDonnell J.M.
        • et al.
        Genital tract papillomavirus type 6 in recurrent conjunctival papilloma.
        Arch Ophthalmol. 1986; 104: 1814
        • Negrini B.P.
        • Schiffmann M.H.
        • Kurman R.J.
        • et al.
        Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix.
        Cancer Res. 1990; 50: 4670
        • Odrich M.G.
        • Jakobiec F.A.
        • Lancaster W.D.
        • et al.
        A spectrum of bilateral squamous conjunctival tumors associated with human papillomavirus type 16.
        Ophthalmology. 1991; 98: 628
        • Odunsi K.
        • Terry G.
        • Ho L.
        • et al.
        Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA-DQ alleles.
        Int J Cancer. 1996; 67: 595
        • Ong C-K
        • Chan S-Y
        • Campo M.S.
        • et al.
        Evolution of human papillomavirus type 18: and ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups.
        J Virol. 1993; 67: 6424
        • Orth G.
        Epidermodysplasia verruciformis.
        in: Salzman N.P. Howley P.M. The Papovaviridae, vol 2. Plenum Press, New York1987: 199
        • Park K-C
        • Kim K-H
        • Youn S-W
        • et al.
        Heterogeneity of human papillomavirus DNA in a patient with Bowenoid Papulosis that progressed to squamous cell carcinoma.
        Br J Dermatol. 1998; 139: 1087
        • Public Health Laboratory Service Communicable Disease Surveillance Centre
        Sexually transmitted disease in Britain: 1985–6.
        Genitourin Med. 1989; 65: 117

      81. Rasmussen KA: Verrucaeplantares: Symptomatology and Epidemiology. Vopenhagen, 1958

        • Reichman R.C.
        • Strike D.G.
        Pathogenesis and treatment of human genital papillomavirus infections: A review.
        Antiviral Res. 1989; 11: 109
        • Rogozinski T.T.
        • Jablonska S.
        • Jarzabek-Chorzelska M.
        Role of cell-mediated immunity in spontaneous regression of plane warts.
        Int J Dermatol. 1988; 27: 322
        • Sasagawa T.
        • Dong Y-Z
        • Saijoh K.
        • et al.
        Human papillomavirus infection and risk determinants for squamous intraepithelial lesion and cervical cancer in Japan.
        Jpn J Cancer Res. 1997; 88: 376
        • Scheffner M.
        • Werness B.A.
        • Huibregste J.M.
        • et al.
        The E6 oncoprotein encoded by the papillomavirus types 16 and 18 promotes the degradation of p 53.
        Cell. 1990; 63: 1129
        • Schneider A.
        Pathogenesis of genital HPV infection.
        Genitourin Med. 1993; 69: 165
        • Shah K.V.
        Human papillomaviruses (including wart viruses).
        in: Gorbach S.L. Bartlett J.G. Blacklow N.R. Infectious Diseases. ed 2. WB Saunders, Philadelphia1998: 2101
        • Shah K.V.
        • Howley P.M.
        Papillomaviruses.
        in: Fields B.N. Knipe D.M. Howley P.M. Fields Virology. ed 2. Raven Press, New York1990 (p 1651, 1658)
        • Slattery M.L.
        • Overall Jr, J.C.
        • Abbott T.M.
        • et al.
        Sexual activity, contraception, genital infections, and cervical cancer: Support for a sexually transmitted disease hypothesis.
        Am J Epidemiol. 1989; 130: 248
        • Snijders P.J.F.
        • Schulten E.A.J.M.
        • Mullink H.
        Detection of human papillomavirus and Epstein-Barr virus DNA sequences on oral mucosa of HIV infected patients by the polymerase chain reaction.
        Am J Pathol. 1990; 137: 659
        • Stoler M.H.
        • Whitbeck A.
        • Wolinsky S.M.
        • et al.
        Infectious cycle of papillomavirus type 11 in human foreskin xenografts in nude mice.
        J Virol. 1990; 64: 3310
        • Stoler M.H.
        • Wolinsky S.M.
        • Whitbeck A.
        • et al.
        Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes.
        Virology. 1989; 172: 331
        • Strand A.
        • Rylander E.
        • Wilander E.
        • et al.
        HPV infection in male partners of women with squamous intraepithelial neoplasia and/or high-risk HPV.
        Acta Derm Venereol. 1995; 75: 312
        • Tagami H.
        • Aiba S.
        • Rokugo M.
        Immunohistochemical analysis of the mechanism underlying spontaneous regression phenomenon of numerous flat wars [abstract].
        J Invest Dermatol. 1985; 84: 310
        • Tagami H.
        • Aiba S.
        • Rokugo M.
        Regression of flat warts and common warts.
        Clin Dermatol. 1985; 3: 170
        • Tagami H.
        • Takigawa M.
        • Ogino A.
        • et al.
        Spontaneous regression of plane warts after inflammation: Clinical and histologic studies in 25 cases.
        Arch Dermatol. 1977; 113: 1209
        • Terai M.
        • Takagi M.
        • Matsukura T.
        • et al.
        Oral wart associated with human papillomavirus type 2.
        J Oral Pathol Med. 1999; 28: 137
        • Trottier A-M
        • Coutlee F.
        • Leduc R.
        • et al.
        Human immunodeficiency virus is a major risk factor for detection of human papillomavirus DNA in esophageal brushings.
        Clin Infect Dis. 1997; 24: 565
        • Uezato H.
        • Hagiwara K.
        • Ramuzi S.T.
        • et al.
        Detection of human papillomavirus type 56 in extragenital Bowen’s disease.
        Acta Derm Venereol. 1999; 79: 311
        • Warhol M.J.
        • Gee B.
        The expression of histocompatibility antigen HLA-DR in cervical squamous epithelium infected with human papilloma virus.
        Mod Pathol. 1989; 2: 101
        • Werness B.A.
        • Levine A.J.
        • Howley P.M.
        Association of human papillomavirus types 16 and 18 E6 proteins with p 53.
        Science. 1990; 248: 76
        • Wheeler C.M.
        • Parmenter C.A.
        • Hunt M.S.
        • et al.
        Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico Student Health Center.
        Sex Transm Dis. 1993; 20: 286

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30060-X

      Copyright

      © 2000 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX